GLAXY 3.2 SPINAL SYSTEM

K043020 · Medtronic Sofamor Danek · KWP · Jan 7, 2005 · Orthopedic

Device Facts

Record IDK043020
Device NameGLAXY 3.2 SPINAL SYSTEM
ApplicantMedtronic Sofamor Danek
Product CodeKWP · Orthopedic
Decision DateJan 7, 2005
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3050
Device ClassClass 2
AttributesTherapeutic

Intended Use

The GALAXY™ 3.2 Spinal System is intended to help provide immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar, cervical and/or sacral spine. The GALAXY™ 3.2 Spinal System implant components can be rigidly locked into a variety of configurations, with each construct being tailor-made for the individual case. If necessary, the GALAXY™ 3.2 Spinal System can be connected to the VERTEX™ Reconstruction System through a rod connector.

Device Story

GALAXY™ 3.2 Spinal System is a posterior spinal interlaminal fixation orthosis; consists of titanium/titanium alloy screws, hooks, rods, and connectors. Surgeon-assembled construct; tailor-made for individual patient anatomy; provides immobilization and stabilization as adjunct to spinal fusion. Used in thoracic, lumbar, cervical, and sacral spine. Compatible with other Medtronic spinal systems (TSRH®, CD HORIZON®, DYNALOK™, VERTEX™) and ATLAS™ cable. Operates via rigid locking of components to rods. Intended for prescription use by surgeons in clinical settings to treat degenerative conditions, trauma, and tumors.

Clinical Evidence

No clinical data provided. Substantial equivalence based on technological characteristics and intended use compared to predicate device.

Technological Characteristics

Materials: medical grade titanium or titanium alloy. Components: screws, hooks, rods, connectors. Configuration: modular, rigid locking. Connectivity: compatible with existing Medtronic spinal systems via rod connectors. Sterilization: not specified. Energy source: none (mechanical).

Indications for Use

Indicated for patients requiring fusion of cervical and thoracic spine (C1-T3) for DDD (discogenic neck pain), spondylolisthesis, spinal stenosis, fracture, dislocation, failed fusion, or tumors. Hooks/rods indicated for stabilization following reduction of fracture/dislocation or trauma in cervical/upper thoracic spine. Screws limited to T1-T3 thoracic conditions; not for posterior cervical spine.

Regulatory Classification

Identification

A spinal interlaminal fixation orthosis is a device intended to be implanted made of an alloy, such as stainless steel, that consists of various hooks and a posteriorly placed compression or distraction rod. The device is implanted, usually across three adjacent vertebrae, to straighten and immobilize the spine to allow bone grafts to unite and fuse the vertebrae together. The device is used primarily in the treatment of scoliosis (a lateral curvature of the spine), but it also may be used in the treatment of fracture or dislocation of the spine, grades 3 and 4 of spondylolisthesis (a dislocation of the spinal column), and lower back syndrome.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K043020 # GALAXY™ 3.2 Spinal System Summary of Safety and Effectiveness October 2004 Medtronic Sofamor Danek, Inc. USA 1. Company: 1800 Pyramid Place Memphis, TN 38132 (901) 396-3133 ### Proposed Proprietary Trade Name: GALAXY(M 3.2 Spinal System II. #### III. Spinal Interlaminal Fixation Orthosis #### IV. Product Description The GALAXY™ 3.2 Spinal System consists of a variety of shapes and sizes of screws, hooks, rods and connecting components, which can be rigidly locked to the rod in a variety of configurations, with each construct being tailor-made for the individual case. This system is intended for posterior use only. Titanium implant components from other previously cleared Medtronic Sofamor Danek Spinal Systems can be used in conjunction with the GALAXY™ 3.2 Spinal System. These systems include the TSRH®, CD HORIZON®, DYNALOK™ PLUS, DYNALOK CLASSIC™ spinal systems and VERTEX™ Reconstruction Systems. Additionally, titanium ATLAS cable may be used with this system at the surgeon's discretion. The GALAXY™ 3.2 Spinal System is fabricated from medical grade titanium or titanium alloy. The GALAXY™ 3.2 Spinal System is intended to help provide immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar, cervical and/or sacral spine. The GALAXY™ 3.2 Spinal System implant components can be rigidly locked into a variety of configurations, with each construct being tailor-made for the individual case. If necessary, the GALAXY™ 3.2 Spinal System can be connected to the VERTEX™ Reconstruction System through a rod connector. ### V. Indications When intended to promote fusion of the cervical spine and the thoracic spinc, (CI-T3), the GALAXYTM 3.2 Spinal System is indicated for the following: DDD (neck pain of discogenic origin with degencration of the disc confirmed by history and radiographic studies), spondylolisthesis, spinal stenosis, fracture, dislocation, failed previous fusion and/or tumors. # Hooks and Rods The hooks and rods are also intended to provide stabilization to promote fusion following reduction of fracture/dislocation or trauma in the cervical/upper thoracic (C1-T3) spine. Page 1 of 2 0000005 {1}------------------------------------------------ # Screws/Connectors The use of screws is limited to placement in T1-T3 only. Screws are not labeled to be placed in the posterior cervical spine. Titanium ATLAS™ Cable used with the GALAXY™ 3.2 Spinal System allows for cable attachment to the posterior cervical or thoracic spine. ### VI. Substantial Equivalence VI. substantially equivalent to VERTEX™ Reconstruction System components previously cleared in K042402. Page 2 of 2 {2}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus symbol. The logo is simple and recognizable, and it is often used to represent the U.S. Department of Health & Human Services. Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JAN - 7 2005 Mr. Richard Treharne, Ph.D. Senior Vice President Regulatory Affairs Medtronic Sofamor Danek, Inc. 1800 Pyramid Place Memphis, Tennessee 38132 Re: K043020 Trade/Device Name: Galaxy™ 3.2 Spinal System Regulation Number: 21 CFR 888.3050 Regulation Name: Spinal interlaminal fixation orthosis Regulatory Class: II Product Code: KWP Dated: November 1, 2004 Received: November 3, 2004 Dear Dr. Treharne: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ Page 2 - Richard W. Treharne, Ph.D. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally presticated predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ 510(k) Number (if known): | 043020 Device Name: _________________________________________________________________________________________________________________________________________________________________ Indications for Use When intended to promote fusion of the cervical spine and the thoracic spine, (C1-T3), the GALAXY™ 3.2 Spinal System is indicated for the following: DDD (neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), spondylolisthesis, spinal stenosis, fracture, dislocation, failed previous fusion and/or tumors. ### Hooks and Rods The hooks and rods are also intended to provide stabilization to promote fusion following reduction of fracture/dislocation or trauma in the cervical/upper thoracic (C1-T3) spine. ### Screws/Connectors The use of screws is limited to placement in T1-T3 in treating thoracic conditions only. Screws are not intended to be placed in the cervical spine. Titanium ATLAS™ Cable used with the GALAXY™ 3.2 Spinal System allows for cable attachment to the posterior cervical or thoracic spine. AND/OR Over-The-Counter Use Prescription Use X (21 CFR 807 Subpart C) (Part 21 CFR 801 Subpart D) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Division Sign Off Division of General, Restorative, and Neurological Devices 510(k) Number K043020 0000003
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...